Annual Working Capital
$67.22 M
+$6.15 M+10.07%
December 1, 2024
Summary
- As of March 10, 2025, XERS annual working capital is $67.22 million, with the most recent change of +$6.15 million (+10.07%) on December 1, 2024.
- During the last 3 years, XERS annual working capital has risen by +$3.66 million (+5.76%).
- XERS annual working capital is now -45.79% below its all-time high of $124.00 million, reached on December 31, 2020.
Performance
XERS Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$67.22 M
-$4.57 M-6.36%
December 31, 2024
Summary
- As of March 10, 2025, XERS quarterly working capital is $67.22 million, with the most recent change of -$4.57 million (-6.36%) on December 31, 2024.
- Over the past year, XERS quarterly working capital has stayed the same.
- XERS quarterly working capital is now -52.00% below its all-time high of $140.04 million, reached on March 31, 2019.
Performance
XERS Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
XERS Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10.1% | 0.0% |
| 3 y3 years | +5.8% | -5.3% |
| 5 y5 years | +11.8% | -5.3% |
XERS Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -40.6% | +10.1% | -40.6% | +10.1% |
| 5 y | 5-year | -45.8% | +11.8% | -50.6% | +11.8% |
| alltime | all time | -45.8% | +119.3% | -52.0% | +71.5% |
Xeris Biopharma Holdings Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | - | $67.22 M(-6.4%) |
| Dec 2024 | $67.22 M(+10.1%) | - |
| Sep 2024 | - | $71.79 M(-24.3%) |
| Jun 2024 | - | $94.85 M(-5.3%) |
| Mar 2024 | - | $100.20 M(+64.1%) |
| Dec 2023 | $61.07 M(-46.0%) | $61.07 M(-14.0%) |
| Sep 2023 | - | $71.01 M(-6.6%) |
| Jun 2023 | - | $76.06 M(-9.5%) |
| Mar 2023 | - | $84.09 M(-25.7%) |
| Dec 2022 | $113.20 M(+78.1%) | $113.20 M(+40.9%) |
| Sep 2022 | - | $80.36 M(-16.9%) |
| Jun 2022 | - | $96.66 M(-13.0%) |
| Mar 2022 | - | $111.06 M(+74.7%) |
| Dec 2021 | $63.56 M | $63.56 M(-27.0%) |
| Sep 2021 | - | $87.08 M(-20.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2021 | - | $109.12 M(-18.1%) |
| Mar 2021 | - | $133.20 M(+7.4%) |
| Dec 2020 | $124.00 M(+106.2%) | $124.00 M(-9.0%) |
| Sep 2020 | - | $136.20 M(+2.0%) |
| Jun 2020 | - | $133.58 M(+59.7%) |
| Mar 2020 | - | $83.64 M(+39.1%) |
| Dec 2019 | $60.15 M(-44.2%) | $60.15 M(-31.8%) |
| Sep 2019 | - | $88.18 M(-16.1%) |
| Jun 2019 | - | $105.14 M(-24.9%) |
| Mar 2019 | - | $140.04 M(+30.0%) |
| Dec 2018 | $107.73 M(+174.9%) | $107.73 M(-15.5%) |
| Sep 2018 | - | $127.46 M(-0.3%) |
| Jun 2018 | - | $127.84 M(+152.4%) |
| Mar 2018 | - | $50.64 M(+29.2%) |
| Dec 2017 | $39.19 M(+27.9%) | $39.19 M |
| Dec 2016 | $30.65 M | - |
FAQ
- What is Xeris Biopharma Holdings annual working capital?
- What is the all time high annual working capital for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings annual working capital year-on-year change?
- What is Xeris Biopharma Holdings quarterly working capital?
- What is the all time high quarterly working capital for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings quarterly working capital year-on-year change?
What is Xeris Biopharma Holdings annual working capital?
The current annual working capital of XERS is $67.22 M
What is the all time high annual working capital for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high annual working capital is $124.00 M
What is Xeris Biopharma Holdings annual working capital year-on-year change?
Over the past year, XERS annual working capital has changed by +$6.15 M (+10.07%)
What is Xeris Biopharma Holdings quarterly working capital?
The current quarterly working capital of XERS is $67.22 M
What is the all time high quarterly working capital for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high quarterly working capital is $140.04 M
What is Xeris Biopharma Holdings quarterly working capital year-on-year change?
Over the past year, XERS quarterly working capital has changed by $0.00 (0.00%)